問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Tri-Service General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2018-10-15 - 2019-11-30
Condition/Disease
Influenza
Test Drug
GCFLU Quadrivalent Pre-filled Syringe inj.
Participate Sites4Sites
Terminated4Sites
Division of Infectious Disease
2020-12-26 - 2022-06-30
COVID-19
MVC-COV1901 vaccine
Participate Sites11Sites
Not yet recruiting7Sites
Recruiting1Sites
Terminated3Sites
2019-04-01 - 2022-12-31
Participate Sites8Sites
Terminated7Sites
non-squamous non-small cell lung cancer
Durvalumab、Tremelimumab
Recruiting8Sites
Division of General Internal Medicine
2018-09-01 - 2022-12-31
Hepatocellular Carcinoma (HCC)
nivolumab﹝Opdivo﹞/ ipilimumab ﹝Yervoy﹞
Participate Sites9Sites
2011-08-01 - 2014-07-31
Participate Sites5Sites
Terminated5Sites
2008-01-19 - 2009-11-18
Participate Sites2Sites
Terminated2Sites
2014-05-06 - 2018-11-12
Participate Sites1Sites
Terminated1Sites
2021-12-04 - 2023-12-31
Participate Sites10Sites
Recruiting10Sites
2007-06-01 - 2009-02-28
全部
